Recorded presentation

Kimberly R. Thomas, MPH, CHES¹, Catherine A. McLean, MD¹, Wayne D. Johnson, MSPH², Debra J. Mosure, PhD¹, and MSM Prevalence Monitoring Project³. (1) Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS E-02, Atlanta, GA 30333, 404-639-8467, CVM9@cdc.gov, (2) Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS E-37, Atlanta, GA 30333, (3) Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS E-02, Atlanta, GA 30333

In 1999, the Centers for Disease Control and Prevention (CDC) established the National MSM Prevalence Monitoring Project to assess the prevalence of and trends in sexually transmitted diseases (STD), TB, and HIV risk behaviors among men who have sex with men (MSM) in clinics serving a large number of MSM. The MSM Prevalence Monitoring Project includes MSM attending STD clinics, HIV care clinics, primary care clinics, and bathhouses in Boston, Chicago, Denver, District of Columbia, Houston, Long Beach, New York City, Philadelphia, San Francisco, and Seattle. Data are collected as part of routine patient care and include age, race, STD symptoms, and chlamydia, gonorrhea, syphilis, TB, and HIV test results. Risk behaviors include number and sex of sex partners, sexual practices, and condom use. City-specific median STD and HIV test positivity and ranges are calculated. In 2002, data were collected from over 20,000 MSM visits from 12 STD clinics, six HIV care clinics, four primary care clinics, and two bathhouses. Median gonorrhea positivity was 17.1% (range: 11.4%-23.0%), median chlamydia positivity was 7.2% (range: 4.7%-11.9%), and median syphilis seroreactivity was 8.0% (range: 3.6%-12.1%). Median HIV positivity, excluding persons previously known to be HIV positive, was 5.1% (range: 1.9%-10.6%). The MSM Prevalence Monitoring Project provides a unique source of national STD, HIV, and behavioral risk data on a large population of MSM seeking care in a wide variety of facilities. These data may be used to enhance local STD and HIV prevention services for MSM.

Learning Objectives: At the conclusion of the session, the participant will be able to

• Describe the Centers for Disease Control and Prevention MSM Prevalence Monitoring Project.
• Identify a source of national STD, TB, and HIV prevalence data for MSM.
• Understand how the Centers for Disease Control and Prevention MSM Prevalence Monitoring Project can be used to guide local program activities.

Keywords: Gay Men, STD

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

Recorded presentation